pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
karus-therapeutics PRESS RELEASE ARCHIVE
Dec 4, 2019
Karus Therapeutics to Announce Positive New Data from Phase I Relapsed/Refractory B-Cell Lymphoma Trial at ASH
Sep 18, 2017
Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial
Oct 5, 2016
Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center
Dec 10, 2015
Karus Therapeutics Announces Strategic Collaboration with The University of Texas MD Anderson Cancer Center
Dec 17, 2012
Karus Therapeutics Announces Collaboration with Babraham Institute to Explore PI3 Kinase Inhibitors in the Treatment of Inflammatory Diseases
Sep 6, 2012
Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors
